Welcome to our dedicated page for DOCGO news (Ticker: DCGO), a resource for investors and traders seeking the latest updates and insights on DOCGO stock.
DocGo Inc (DCGO) is a leader in mobile health services and integrated medical mobility solutions, providing on-site care and emergency transport across the US and UK. This news hub offers investors and professionals centralized access to official corporate announcements and market developments.
Track DCGO's latest press releases, including service expansions, strategic partnerships, and operational milestones across its three core segments: Mobile Health Services, Transportation Services, and Corporate operations. Our curated collection ensures timely updates on earnings reports, regulatory filings, and technological advancements in last-mile healthcare delivery.
This resource serves as a comprehensive reference for understanding DocGo's evolving role in bridging healthcare accessibility gaps through mobile clinics, virtual care management, and specialized patient transport solutions. Bookmark this page for direct access to verified information about DCGO's innovations in event medical support, corporate wellness programs, and emergency response logistics.
DocGo (NASDAQ: DCGO) faces a significant legal investigation by Schubert Jonckheer & Kolbe LLP regarding alleged false statements and insider trading. A federal judge has allowed key claims in a securities fraud lawsuit to proceed, focusing on alleged misrepresentations about the former CEO's educational background and business operations.
The lawsuit claims that between April 2022 and September 2023, DocGo made misleading statements about the CEO's graduate degree and misrepresented relationships with UnitedHealthcare and Medicaid enrollment programs in New York. During this period, insiders sold approximately $4 million in company stock. The stock price dropped 25% after these revelations came to light in September 2023.
DocGo (Nasdaq: DCGO) has secured a new contract with the County of San Diego to provide community vaccination services. The program focuses on expanding healthcare access in San Diego's East and North-Central neighborhoods, particularly targeting underserved populations.
The comprehensive vaccination program will be conducted at various locations including schools, houses of worship, public parks, neighborhood centers, and through in-home services. DocGo will collaborate with county officials, community organizations, and trusted agencies to promote program awareness and improve immunization equity.
This marks DocGo's first partnership with San Diego County, complementing their existing mobile health services provided through insurance payers in the region. The initiative aims to ensure accessibility for disabled, frail, and transportation-limited individuals.
DocGo (Nasdaq: DCGO), a provider of technology-enabled mobile health and medical transportation services, has scheduled its Q2 2025 earnings release for Thursday, August 7, 2025, after market close.
The company will host a conference call and webcast to discuss the results at 5:00 p.m. ET the same day. Investors can access the call via U.S. toll-free number (1-800-717-1738) or international number (1-646-307-1865) using Conference ID 75731. A webcast will be available through the Investors section of DocGo's website.
DocGo (Nasdaq: DCGO) announced that its subsidiary Ambulnz has secured a multi-year $3.4 million contract to provide medical transportation services to the Albany Stratton VA Medical Center. The services will include basic life support, advanced life support, and critical care ambulance services for veterans requiring transportation to and from VA facilities in the Capital Region.
The Albany Stratton VA Medical Center serves over 50,000 veterans through its main campus and ten community-based outpatient clinics. The facility features 150 inpatient beds and handles approximately 700 inpatient admissions and 450,000 outpatient visits annually. DocGo commenced services on July 1, 2025.
DocGo (Nasdaq: DCGO), a technology-enabled mobile health services provider, has won the "Compliance Management Innovation Award" at the 2025 MedTech Breakthrough Awards. The company's Compliance Program was recognized for its excellence in managing ethics, compliance, and risk management while adapting to emerging technologies and risks.
The program features an annual compliance survey for confidential employee feedback and incorporates the Department of Justice's 2024 Evaluation of Corporate Compliance Programs. DocGo's 2025 Compliance & Audit Work Plan includes risk assessments from key stakeholders, addresses emerging technology risks, and enhances cybersecurity procedures for HIPAA privacy compliance.
DocGo (Nasdaq: DCGO), a leading provider of technology-enabled mobile health services, has scheduled its first quarter 2025 financial results announcement for Thursday, May 8th, 2025, after market close.
The company will host a conference call and webcast at 5:00 p.m. ET to discuss the Q1 2025 results. Investors can join via phone using U.S. number 1-800-717-1738 or international number 1-646-307-1865 (Conference ID: 65854). A webcast option is available through the Investors section of DocGo's website.
DocGo (Nasdaq: DCGO), a technology-enabled mobile health services provider, has achieved the Great Place To Work Certification™ for the third consecutive time. The certification, based on current employee feedback, shows DocGo rated 31% higher than the average US company.
According to CEO Lee Bienstock, the company prioritizes creating a positive environment that supports and celebrates team members, with career development being a core value. The certification, awarded through real-time employee feedback, indicates DocGo's excellence in workplace culture.
Research from Great Place To Work shows that job seekers are 4.5 times more likely to find quality leadership at certified workplaces. Additionally, employees at certified companies are 93% more likely to look forward to work and twice as likely to receive fair compensation, profit sharing, and promotion opportunities.